Lee, J., Botesteanu, D., Tomita, Y., Yuno, A., Lee, M., Kohn, E. C., . . . Trepel, J. B. (2019). Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8(+) T cells compared with women with BRCA wild-type disease during the early disease course. Oncol Lett.
Chicago-стиль цитированияLee, Jung-Min, et al. "Patients With BRCA Mutated Ovarian Cancer May Have Fewer Circulating MDSC and More Peripheral CD8(+) T Cells Compared With Women With BRCA Wild-type Disease During the Early Disease Course." Oncol Lett 2019.
MLA-цитированиеLee, Jung-Min, et al. "Patients With BRCA Mutated Ovarian Cancer May Have Fewer Circulating MDSC and More Peripheral CD8(+) T Cells Compared With Women With BRCA Wild-type Disease During the Early Disease Course." Oncol Lett 2019.